BPS Bioscience

BPS Bioscience operates as a critical enabler for drug discovery, offering both off-the-shelf research tools and custom development services. Its business model is built on providing the essential biological components—proteins, cells, and assays—needed to validate targets and screen compounds, positioning it as a specialized CRO and reagent supplier. The company holds ISO 9001:2015 certification, emphasizing quality, and its product lines are strategically aligned with high-growth research areas like immuno-oncology, cell therapy, and targeted protein degradation. As a private company, it generates revenue through product sales and fee-for-service contracts, supporting clients from early research through preclinical development.

Integrated suite of capabilities in protein expression & purification, cell line engineering (including CRISPR), assay development (biochemical & cell-based), viral vector production (lentivirus, AAV), and custom screening services for drug discovery.

BPS Bioscience competes in the fragmented life science tools and specialized CRO market. Major competitors include large reagent suppliers like Thermo Fisher, Abcam, and Bio-Techne, as well as numerous boutique CROs focusing on assay development and screening. Differentiation is achieved through its focused catalog on specific pathways, integrated service offerings, and ISO-certified quality.